Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
-0.25 (-2.11%)
At close: May 17, 2024, 4:00 PM
-0.58 (-5.00%)
After-hours: May 17, 2024, 6:04 PM EDT

Y-mAbs Therapeutics Revenue

Y-mAbs Therapeutics had revenue of $84.50M in the twelve months ending March 31, 2024, with 12.62% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.93M, a -1.58% decrease year-over-year. In the year 2023, Y-mAbs Therapeutics had annual revenue of $84.82M with 29.96% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
509.04M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202384.82M19.55M29.96%
Dec 31, 202265.27M30.37M87.03%
Dec 31, 202134.90M14.15M68.18%
Dec 31, 202020.75M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.52B
Aveanna Healthcare Holdings 1.92B
Cross Country Healthcare 1.78B
InnovAge Holding 741.33M
OmniAb 21.05M
Absci 5.35M
Cibus 2.32M
Revenue Rankings